Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Matthias Löhle
Controversies in Neurology: Why Monoamine Oxidase B Inhibitors Could Be a Good Choice for the Initial Treatment of Parkinson's Disease
BMC Neurology
Medicine
Neurology
Related publications
The PPARγ Agonist Pioglitazone Is Effective in the MPTP Mouse Model of Parkinson's Disease Through Inhibition of Monoamine Oxidase B
British Journal of Pharmacology
Pharmacology
Praziquantel Could Be the Appropriate Choice for the Diagnostic Treatment of Schistosomiasis
Internal Medicine
Internal Medicine
Medicine
Structure-Activity Relationship Analysis of 3-Phenylcoumarin-Based Monoamine Oxidase B Inhibitors
Frontiers in Chemistry
Chemistry
Effects of Monoamine Oxidase Inhibitors on Cocaine Discrimination in Rats
Behavioural Pharmacology
Psychiatry
Mental Health
Pharmacology
Erratum To: Prescribing Pattern and Resource Utilization of Monoamine Oxidase-B Inhibitors in Parkinson Treatment: Comparison Between Rasagiline and Selegiline
Neurological Sciences
Dermatology
Medicine
Psychiatry
Neurology
Mental Health
Human Monoamine Oxidase A: Structure and Control of Opening the Entry for Substrates/Inhibitors
Acta Crystallographica Section A Foundations of Crystallography
Design, Synthesis and Pharmacological Evaluation of New Coumarin Derivatives as Monoamine Oxidase a and B Inhibitors
Authors' Response to "Praziquantel Could Be the Appropriate Choice for the Diagnostic Treatment of Schistosomiasis"
Internal Medicine
Internal Medicine
Medicine
Synthesis and Evaluation of Iodinated Benzamide Derivative as Selective and Reversible Monoamine Oxidase B Inhibitors.
Chemical and Pharmaceutical Bulletin
Medicine
Drug Discovery
Chemistry